Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Journal: Nature Medicine

Published: 2018-07-16

DOI: 10.1038/s41591-018-0101-z

Affiliations: 7

Authors: 23

Go to article
Institutions FC
Department of Hematology and Oncology, SMC, South Korea 0.43
Merck & Co., Inc., United States of America (USA) 0.30
Guardant Health, Inc., United States of America (USA) 0.09
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.04
Department of Pathology and Translational Genomics, SMC, South Korea 0.04
Department of Gastroenterology, SMC, South Korea 0.04
Department of General Surgery, SMC, South Korea 0.04

Return